FinalDose: Programmable DNA drug destroying all cancers, unlocking 80% of targets. Headquartered in London, United Kingdom. Current operating status: active.
Oomira checked this YC company record against source evidence and keeps the current facts, observed dates, and provenance visible before the interactive app loads.
This frozen capsule corroborates the selected YC record; no superseded claims are attached for FinalDose. The page still exposes the dated facts and sources Oomira used.
Open the full YC audit or continue into the interactive frozen world below.